Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Pat...
Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients
About this item
Full title
Author / Creator
Cheng, Yong , Wang, Yue , Zhou, Xiao‐fang , You, Lai‐wei , Xie, Xiao‐yi , Li, Hao , Wu, Mandi and Guo, Jianrong
Publisher
England: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
England: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
ABSTRACT
Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer, constituting 75%–85% of all liver cancer cases. Despite advances in understanding HCC mechanisms and treatment options, challenges remain and further research is needed to uncover new therapeutic targets and improve patient outcomes. intraoperative c...
Alternative Titles
Full title
Identification of Safety Biomarkers for Autologous Blood Transfusion in Hepatocellular Carcinoma Patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11975049
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11975049
Other Identifiers
ISSN
1582-1838,1582-4934
E-ISSN
1582-4934
DOI
10.1111/jcmm.70504
